Denice Torres - 20 Jun 2023 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
KRTX
Transactions as of
20 Jun 2023
Transactions value $
$0
Form type
4
Filing time
22 Jun 2023, 16:03:11 UTC
Previous filing
15 Jun 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Award $0 +990 $0 990 20 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Award $0 +1,904 $0 1,904 20 Jun 2023 Common Stock 1,904 $237.7 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such dates.
F2 This option shall vest in full upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such dates.